These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 9711594)

  • 1. Adeno-associated virus vectors for gene therapy of cystic fibrosis.
    Flotte TR; Carter BJ
    Methods Enzymol; 1998; 292():717-32. PubMed ID: 9711594
    [No Abstract]   [Full Text] [Related]  

  • 2. Adeno-associated virus for cystic fibrosis gene therapy.
    Martini SV; Rocco PR; Morales MM
    Braz J Med Biol Res; 2011 Nov; 44(11):1097-104. PubMed ID: 21952739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cystic fibrosis gene therapy.
    Colledge WH
    Curr Opin Genet Dev; 1994 Jun; 4(3):466-71. PubMed ID: 7522673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cationic lipid formulations for intracellular gene delivery of cystic fibrosis transmembrane conductance regulator to airway epithelia.
    Cheng SH; Marshall J; Scheule RK; Smith AE
    Methods Enzymol; 1998; 292():697-717. PubMed ID: 9711593
    [No Abstract]   [Full Text] [Related]  

  • 5. Safety of single-dose administration of an adeno-associated virus (AAV)-CFTR vector in the primate lung.
    Conrad CK; Allen SS; Afione SA; Reynolds TC; Beck SE; Fee-Maki M; Barrazza-Ortiz X; Adams R; Askin FB; Carter BJ; Guggino WB; Flotte TR
    Gene Ther; 1996 Aug; 3(8):658-68. PubMed ID: 8854091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors influencing adeno-associated virus-mediated gene transfer to human cystic fibrosis airway epithelial cells: comparison with adenovirus vectors.
    Teramoto S; Bartlett JS; McCarty D; Xiao X; Samulski RJ; Boucher RC
    J Virol; 1998 Nov; 72(11):8904-12. PubMed ID: 9765435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of adeno-associated virus vectors for gene therapy of cystic fibrosis.
    Carter BJ; Flotte TR
    Curr Top Microbiol Immunol; 1996; 218():119-44. PubMed ID: 8794249
    [No Abstract]   [Full Text] [Related]  

  • 8. Safety and biological efficacy of an adeno-associated virus vector-cystic fibrosis transmembrane regulator (AAV-CFTR) in the cystic fibrosis maxillary sinus.
    Wagner JA; Messner AH; Moran ML; Daifuku R; Kouyama K; Desch JK; Manley S; Norbash AM; Conrad CK; Friborg S; Reynolds T; Guggino WB; Moss RB; Carter BJ; Wine JJ; Flotte TR; Gardner P
    Laryngoscope; 1999 Feb; 109(2 Pt 1):266-74. PubMed ID: 10890777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene Therapy for Cystic Fibrosis Paved the Way for the Use of Adeno-Associated Virus in Gene Therapy.
    Guggino WB; Cebotaru L
    Hum Gene Ther; 2020 May; 31(9-10):538-541. PubMed ID: 32283956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breathing Easier: Molecular Therapeutics for Cystic Fibrosis.
    Limberis MP
    Hum Gene Ther; 2020 Sep; 31(17-18):905-906. PubMed ID: 32945723
    [No Abstract]   [Full Text] [Related]  

  • 11. Laying the Foundation for Cystic Fibrosis Therapy: An Interview with Michael Boyle.
    Davies K
    Hum Gene Ther; 2020 Sep; 31(17-18):917-920. PubMed ID: 32924627
    [No Abstract]   [Full Text] [Related]  

  • 12. Lentiviral vectors for gene therapy of cystic fibrosis.
    Goldman MJ; Lee PS; Yang JS; Wilson JM
    Hum Gene Ther; 1997 Dec; 8(18):2261-8. PubMed ID: 9449379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase I study of aerosolized administration of tgAAVCF to cystic fibrosis subjects with mild lung disease.
    Aitken ML; Moss RB; Waltz DA; Dovey ME; Tonelli MR; McNamara SC; Gibson RL; Ramsey BW; Carter BJ; Reynolds TC
    Hum Gene Ther; 2001 Oct; 12(15):1907-16. PubMed ID: 11589832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene Therapy for Respiratory Diseases: Progress and a Changing Context.
    Alton EWFW; Boyd AC; Davies JC; Gill DR; Griesenbach U; Harman TE; Hyde S; McLachlan G
    Hum Gene Ther; 2020 Sep; 31(17-18):911-916. PubMed ID: 32746737
    [No Abstract]   [Full Text] [Related]  

  • 15. Correlation between DNA transfer and cystic fibrosis airway epithelial cell correction after recombinant adeno-associated virus serotype 2 gene therapy.
    Flotte TR; Schwiebert EM; Zeitlin PL; Carter BJ; Guggino WB
    Hum Gene Ther; 2005 Aug; 16(8):921-8. PubMed ID: 16076250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of mucoviscidosis, gene CFTR transfer by using adenoviral vectors].
    Bellon G; Pavirani A
    Arch Pediatr; 1996; 3 Suppl 1():82s-87s. PubMed ID: 8795974
    [No Abstract]   [Full Text] [Related]  

  • 17. Gene therapy progress and prospects: cystic fibrosis.
    Griesenbach U; Ferrari S; Geddes DM; Alton EW
    Gene Ther; 2002 Oct; 9(20):1344-50. PubMed ID: 12364999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional characterization of a recombinant adeno-associated virus 5-pseudotyped cystic fibrosis transmembrane conductance regulator vector.
    Sirninger J; Muller C; Braag S; Tang Q; Yue H; Detrisac C; Ferkol T; Guggino WB; Flotte TR
    Hum Gene Ther; 2004 Sep; 15(9):832-41. PubMed ID: 15353038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospects for virus-based gene therapy for cystic fibrosis.
    Flotte TR
    J Bioenerg Biomembr; 1993 Feb; 25(1):37-42. PubMed ID: 8382676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A controlled study of adenoviral-vector-mediated gene transfer in the nasal epithelium of patients with cystic fibrosis.
    Knowles MR; Hohneker KW; Zhou Z; Olsen JC; Noah TL; Hu PC; Leigh MW; Engelhardt JF; Edwards LJ; Jones KR
    N Engl J Med; 1995 Sep; 333(13):823-31. PubMed ID: 7544439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.